Skip to content

Homoeopathy in Benign Prostatic Hyperplasia

Homoeopathic therapy for lower urinary tract symptoms in men with benign prostatic hyperplasia: A randomized multicentric clinical trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2012/05/002649
Enrollment
252
Registered
2012-05-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- LOWER URINARY TRACT SYMPTOMS IN MEN WITH BENIGN PROSTASTIC HYPERPLASIA

Interventions

Intervention1: Homoeopathic Constitutional Medicines: Baryta c., Calc c., Con mac., Puls nig.,Apis, Arg nit., Iod, Lyco, Merc sol., Nat sulph., Acid nit., Phos, Selenium, Sil, Staph, Sulphur, Thuja, A

Sponsors

Central Council for Research in Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ? Men aged between 50-80 years with sign and symptoms of Benign Hyperplasia of Prostate. ? Presence of BPH symptoms with IPSS score > 7. ? Written informed consent ? Patients who can act in accordance with the protocol ? Prostate Specific Antigen PSA level equal to or below 4 ng/mL (to rule out suspected cases of malignancy) ? On ultrasonic examination prostate weight should be > 20g/20cc/20ml).

Exclusion criteria

Exclusion criteria: ? Patients who are not adequately symptomatic (mild according to IPSS). ? Patients with serious underlying medical condition (eg. Severe renal, hepatic disease etc.) ? Do not give informed consent. ? Complete retention of urine for more than 24 hours ? Prostatic carcinoma ? Patients interested for surgery during the next six months. ? Other possible causes of the symptoms such as recurrent Urinary Tract Infection, neurogenic bladder, or urethral stricture.

Design outcomes

Primary

MeasureTime frame
To compare the changes in International Prostate Symptom Score (IPSS)Timepoint: 6 months

Secondary

MeasureTime frame
To compare changes in prostate volume, post void residual urine and uroflometry. To compare the changes in WHO Quality of Life Brief Timepoint: At baseline and six months

Countries

India

Contacts

Public ContactDr Bindu Sharma

Central Council for Research in Homeooapthy

drbinduhomoeo@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 8, 2026